These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17284696)

  • 41. A note on variance estimation in random effects meta-regression.
    Sidik K; Jonkman JN
    J Biopharm Stat; 2005; 15(5):823-38. PubMed ID: 16078388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group.
    Stewart LA; Clarke MJ
    Stat Med; 1995 Oct; 14(19):2057-79. PubMed ID: 8552887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stopping trials for efficacy: an almost unbiased view.
    Goodman SN
    Clin Trials; 2009 Apr; 6(2):133-5. PubMed ID: 19342465
    [No Abstract]   [Full Text] [Related]  

  • 46. "Large-scale randomized evidence: large, simple trials and overviews of trials": discussion. A clinician's perspective on meta-analyses.
    Horwitz RI
    J Clin Epidemiol; 1995 Jan; 48(1):41-4. PubMed ID: 7853046
    [No Abstract]   [Full Text] [Related]  

  • 47. Choice of test for comparing two groups, with particular application to skewed outcomes.
    White IR; Thompson SG
    Stat Med; 2003 Apr; 22(8):1205-15. PubMed ID: 12687651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statistical issues in a metaregression analysis of randomized trials: impact on the dietary sodium intake and blood pressure relationship.
    Greenwood CM; Midgley JP; Matthew AG; Logan AG
    Biometrics; 1999 Jun; 55(2):630-6. PubMed ID: 11318226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Large-scale randomized evidence: large, simple trials and overviews of trials.
    Peto R; Collins R; Gray R
    J Clin Epidemiol; 1995 Jan; 48(1):23-40. PubMed ID: 7853045
    [No Abstract]   [Full Text] [Related]  

  • 50. Meta-analyses and large randomized, controlled trials.
    Stewart LA; Parmar MK; Tierney JF
    N Engl J Med; 1998 Jan; 338(1):61; author reply 61-2. PubMed ID: 9424569
    [No Abstract]   [Full Text] [Related]  

  • 51. Meta-analyses and large randomized, controlled trials.
    Ioannidis JP; Cappelleri JC; Lau J
    N Engl J Med; 1998 Jan; 338(1):59; author reply 61-2. PubMed ID: 9424563
    [No Abstract]   [Full Text] [Related]  

  • 52. On the observed specific and non-specific effects of complex therapeutic interventions: truly separate or complementary?
    Milgrom LR
    Adv Exp Med Biol; 2015; 821():79-92. PubMed ID: 25416112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homoeopathy trials: going nowhere.
    Vandenbroucke JP
    Lancet; 1997 Sep; 350(9081):824. PubMed ID: 9310594
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews.
    Liu P; Ross JS; Ioannidis JP; Dhruva SS; Vasiliou V; Wallach JD
    Clin Trials; 2020 Apr; 17(2):231-234. PubMed ID: 31709809
    [No Abstract]   [Full Text] [Related]  

  • 55. A word from our moderator.
    Shrier I
    JAMA; 2007 Jan; 297(2):156-7; author reply 157. PubMed ID: 17213397
    [No Abstract]   [Full Text] [Related]  

  • 56. The analysis of binary and categorical data from crossover trials.
    Kenward MG; Jones B
    Stat Methods Med Res; 1994 Dec; 3(4):325-44. PubMed ID: 7889226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A word from our moderator.
    Deinum J; van der Wilt GJ
    JAMA; 2007 Jan; 297(2):156; author reply 157. PubMed ID: 17213398
    [No Abstract]   [Full Text] [Related]  

  • 58. Bias and trials stopped early for benefit.
    Korn EL; Freidlin B; Mooney M
    JAMA; 2010 Jul; 304(2):157-8; author reply 158-9. PubMed ID: 20628125
    [No Abstract]   [Full Text] [Related]  

  • 59. Seeing what you want to see in randomised controlled trials. Meta- analyses may suffer from interpretation bias too.
    Lindbaek M
    BMJ; 2000 Oct; 321(7268):1079. PubMed ID: 11053193
    [No Abstract]   [Full Text] [Related]  

  • 60. Remarks on the method of propensity score.
    Pearl J
    Stat Med; 2009 Apr; 28(9):1415-6; author reply 1420-3. PubMed ID: 19340847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.